The pathogenesis of idiopathic pulmonary fibrosis

Therapeutic Advances in Respiratory Disease

Volumn 4, Issue 6, 2010, Pages 367-388

  Coward, William R ^a   Saini, Gauri ^a   Jenkins, Gisli ^a  

^a NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

epithelium; idiopathic pulmonary fibrosis; myofibroblast; transforming growth factor

Indexed keywords

ALPHAVBETA6 INTEGRIN; CHEMOKINE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BLOOD CLOTTING DISORDER; CELL DAMAGE; CELL REGENERATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM; FIBROBLAST; FIBROSING ALVEOLITIS; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG FIBROSIS; LYMPHOCYTE; MEMBRANE DAMAGE; MONOCYTE; MYOFIBROBLAST; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BASEMENT MEMBRANE; CELL PROLIFERATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MYOFIBROBLASTS; PROGNOSIS; PULMONARY ALVEOLI; TRANSFORMING GROWTH FACTOR BETA;

EID: 78649920691     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465810379801     Document Type: Review

References (216)

1. Adcock, I.M., Tsaprouni, L., Bhavsar, P. and Ito, K. ( 2007) Epigenetic regulation of airway inflammation. Curr Opin Immunol 19: 694-700.
2. Alder, J.K., Chen, J.J., Lancaster, L., Danoff, S., Su, S.C., Cogan, J.D. et al. (2008) Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 105: 13051-13056.
3. Ambrosini, V., Cancellieri, A., Chilosi, M., Zompatori, M., Trisolini, R., Saragoni, L. et al. (2003) Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 22: 821-826.
4. Andersson-Sjoland, A., De Alba, C.G., Nihlberg, K., Becerril, C., Ramirez, R., Pardo, A. et al. (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 2129-2140.
5. Andrés, M.E., Burger, C., Peral-Rubio, M.J., Battaglioli, E., Anderson, M.E., Grimes, J. et al. (1999) CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A 96: 9873-9878.
6. Annes, J.P., Chen, Y., Munger, J.S. and Rifkin, D.B. ( 2004) Integrin alphavbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165: 723-734.
7. Antoniades, H.N., Neville-Golden, J., Galanopoulos, T., Kradin, R.L., Valente, A.J. and Graves, D.T. ( 1992) Expression of monocyte chemoattractant protein 1 MRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 89: 5371-5375.
8. Arai, T., Abe, K., Matsuoka, H., Yoshida, M., Mori, M., Goya, S. et al. (2000) Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. Am J Physiol Lung Cell Mol Physiol 278: L914-L922.
9. Araya, J., Cambier, S., Markovics, J.A., Wolters, P., Jablons, D., Hill, A. et al. (2007) Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 117: 3551-3562.
10. Armanios, M. ( 2009) Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 10: 45-61.
11. Armanios, M.Y., Chen, J.J., Cogan, J.D., Alder, J.K., Ingersoll, R.G., Markin, C. et al. (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356: 1317-1326.
12. Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y. and Tamaki, K. ( 2005) Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol 175: 7708-7718.
13. Asano, Y., Ihn, H., Yamane, K., Jinnin, M. and Tamaki, K. ( 2006) Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol 168: 499-510.
14. Atabai, K., Jame, S., Azhar, N., Kuo, A., Lam, M., McKleroy, W. et al. (2009) MFGE8 Diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. J Clin Invest 119: 3713-3722.
15. Ballas, N., Battaglioli, E., Atouf, F., Andrés, M.E., Chenoweth, J., Anderson, M.E. et al. (2001) Regulation of neuronal traits by a novel transcriptional complex. Neuron 31: 353-365.
16. Baran, C.P., Opalek, J.M., McMaken, S., Newland, C.A., O–Brien Jr, J.M., Hunter, M.G. et al. (2007) Important roles for macrophage colony-stimulating factor, Cc chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 176: 78-89.
17. Basset, F., Ferrans, V.J., Soler, P., Takemura, T., Fukuda, Y. and Crystal, R.G. ( 1986) Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 122: 443-461.
18. Bates, R.C., Bellovin, D.I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H. et al. (2005) Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115: 339-347.
19. Beers, M.F. and Mulugeta, S. ( 2005) Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 67: 663-696.
20. Belperio, J.A., Dy, M., Burdick, M.D., Xue, Y.Y., Li, K., Elias, J.A. et al. (2002) Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 27: 419-427.
21. Bertozzi, P., Astedt, B., Zenzius, L., Lynch, K., Lemaire, F., Zapol, W. et al. (1990) Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress Syndrome. N Engl J Med 322: 890-897.
22. Bonner, J.C. ( 2004) Regulation of Pdgf and Its Receptors in Fibrotic Diseases. Cytokine Growth Factor Rev 15: 255-273.
23. Bonniaud, P., Margetts, P.J., Kolb, M., Schroeder, J.A., Kapoun, A.M., Damm, D. et al. (2005) Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active Alk5 kinase inhibitor. Am J Respir Crit Care Med 171: 889-898.
24. Broekelmann, T.J., Limper, A.H., Colby, T.V. and McDonald, J.A. ( 1991) Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 88: 6642-6646.
25. Bucala, R., Spiegel, L.A., Chesney, J., Hogan, M. and Cerami, A. ( 1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
26. Burdick, M.D., Murray, L.A., Keane, M.P., Xue, Y.Y., Zisman, D.A., Belperio, J.A. et al. (2005) Cxcl11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med 171: 261-268.
27. Car, B.D., Meloni, F., Luisetti, M., Semenzato, G., Gialdroni-Grassi, G. and Walz, A. ( 1994) Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149: 655-659.
28. Caraci, F., Gili, E., Calafiore, M., Failla, M., La Rosa, C., Crimi, N. et al. (2008) TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 57: 274-282.
29. Chambers, R.C. ( 2003) Role of coagulation cascade proteases in lung repair and fibrosis. Eur Respir J Suppl 44: 33s-35s.
30. Chang, W., Wei, K., Jacobs, S.S., Upadhyay, D., Weill, D. and Rosen, G.D. (2010) SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J Biol Chem 285: 8196-8206.
31. Chapman, H.A., Allen, C.L. and Stone, O.L. ( 1986) Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 133: 437-443.
32. Chilosi, M., Poletti, V., Zamo, A., Lestani, M., Montagna, L., Piccoli, P. et al. (2003) Aberrant WNT/ beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162: 1495-1502.
33. Chua, F., Dunsmore, S.E., Clingen, P.H., Mutsaers, S.E., Shapiro, S.D., Segal, A.W. et al. (2007) Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol 170: 65-74.
34. Clark, J.G., Dedon, T.F., Wayner, E.A. and Carter, W.G. ( 1989) Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts. J Clin Invest 83: 1505-1511.
35. Clark, J.G. and Kuhn III, C. ( 1982) Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 126: 737-739.
36. Clifford, R.L., Deacon, K. and Knox, A.J. ( 2008) Novel regulation of vascular endothelial growth factor-a (VEGF-a) by transforming growth factor (beta)1: requirement for SMADS, (beta)-catenin, and GSK3(beta). J Biol Chem 283: 35337-35353.
37. Coker, R.K., Laurent, G.J., Jeffery, P.K., Du Bois, R.M., Black, C.M. and McAnulty, R.J. ( 2001) Localisation of transforming growth factor beta1 and beta3 MRNA transcripts in normal and fibrotic human lung. Thorax 56: 549-556.
38. Coker, R.K., Laurent, G.J., Shahzeidi, S., Lympany, P.A., Du Bois, R.M., Jeffery, P.K. et al. (1997) Transforming growth factors-beta 1-beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150: 981-991.
39. Cool, C.D., Groshong, S.D., Rai, P.R., Henson, P.M., Stewart, J.S. and Brown, K.K. ( 2006) Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 174: 654-658.
40. Coward, W.R., Watts, K., Feghali-Bostwick, C.A., Jenkins, G. and Pang, L. (2010) Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol Cell Biol 30: 2874-2886.
41. Coward, W.R., Watts, K., Feghali-Bostwick, C.A., Knox, A. and Pang, L. (2009) Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 29: 4325-4339.
42. de la Cruz, X., Lois, S., Sanchez-Molina, S. and Martinez-Balbas, M.A. ( 2005) Do protein motifs read the histone code? Bioessays 27: 164-175.
43. Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H.M. et al. (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353: 2229-2242.
44. Derynck, R., Akhurst, R.J. and Balmain, A. ( 2001) TGF-beta signaling in tumour suppression and cancer progression. Nat Genet 29: 117-129.
45. Deshmane, S.L., Kremlev, S., Amini, S. and Sawaya, B.E. (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326.
46. Diaz de Leon, A., Cronkhite, J.T., Katzenstein, A.L., Godwin, J.D., Raghu, G., Glazer, C.S. et al. (2010) Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One 5: e10680.
47. Eickelberg, O. and Laurent, G.J. (2010) The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts. Am J Respir Cell Mol Biol 42: 1-2.
48. Eickelberg, O., Pansky, A., Koehler, E., Bihl, M., Tamm, M., Hildebrand, P. et al. (2001) Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine a in lung fibroblasts. FASEB J 15: 797-806.
49. Eitzman, D.T., McCoy, R.D., Zheng, X., Fay, W.P., Shen, T., Ginsburg, D. et al. (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97: 232-237.
50. Elias, J.A. ( 1988) Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 138: 652-658.
51. Emura, M., Nagai, S., Takeuchi, M., Kitaichi, M. and Izumi, T. ( 1990) In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 82: 133-139.
52. Felton, V.M., Borok, Z. and Willis, B.C. ( 2009) N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol 297: L805-L812.
53. Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A. et al. (1998) Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 11: 706-711.
54. Fischle, W., Wang, Y. and David Allis, C. ( 2003) Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475-479.
55. Fujii, M., Hayakawa, H., Urano, T., Sato, A., Chida, K., Nakamura, H. et al. (2000) Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb Res 99: 111-117.
56. Gilani, S.R., Vuga, L.J., Lindell, K.O., Gibson, K.F., Xue, J., Kaminski, N. et al. (2010) CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 5: e8959.
57. Gilligan, D.M., O–Connor, C.M., Ward, K., Moloney, D., Bresnihan, B. and Fitzgerald, M.X. ( 1990) Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 45: 591-596.
58. Gorgoni, B., Caivano, M., Arizmendi, C. and Poli, V. ( 2001) The transcription factor C/EBPbeta is essential for inducible expression of the COX-2 gene in macrophages but not in fibroblasts. J Biol Chem 276: 40769-40777.
59. Gunther, A., Lubke, N., Ermert, M., Schermuly, R.T., Weissmann, N., Breithecker, A. et al. (2003) Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 168: 1358-1365.
60. Guo, W., Flanagan, J., Jasuja, R., Kirkland, J., Jiang, L. and Bhasin, S. ( 2008) The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between SMAD3 and WNT/beta-catenin signaling pathways. J Biol Chem 283: 9136-9145.
61. Guo, W., Shan, B., Klingsberg, R.C., Qin, X. and Lasky, J.A. (2009) Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 297: L864-L870.
62. Gurujeyalakshmi, G. and Giri, S.N. ( 1995) Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 21: 791-808.
63. Haase, M.G., Klawitter, A., Geyer, P. and Baretton, G.B. ( 2007) Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage. J Histochem Cytochem 55: 1167-1172.
64. Hagimoto, N., Kuwano, K., Inoshima, I., Yoshimi, M., Nakamura, N., Fujita, M. et al. (2002) TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168: 6470-6478.
65. Harari, S. and Caminati, A. (2010) IPF: new insight on pathogenesis and treatment. Allergy 65: 537-553.
66. Hashimoto, N., Jin, H., Liu, T., Chensue, S.W. and Phan, S.H. ( 2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113: 243-252.
67. Hattori, N., Sisson, T.H., Xu, Y. and Simon, R.H. ( 1999) Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo. Hum Gene Ther 10: 215-222.
68. Hernandez-Rodriguez, N.A., Cambrey, A.D., Harrison, N.K., Chambers, R.C., Gray, A.J., Southcott, A.M. et al. (1995) Role of thrombin in pulmonary fibrosis. Lancet 346: 1071-1073.
69. Hinz, B. ( 2010) The myofibroblast: paradigm for a mechanically active cell. J Biomech 43: 146-155.
70. Hiwatari, N., Shimura, S., Sasaki, T., Aikawa, T., Ando, Y., Ishihara, H. et al. (1991) Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion. Am Rev Respir Dis 143: 182-185.
71. Hodges, R.J., Jenkins, R.G., Wheeler-Jones, C.P., Copeman, D.M., Bottoms, S.E., Bellingan, G.J. et al. (2004) Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol 165: 1663-1676.
72. Hong, K.M., Belperio, J.A., Keane, M.P., Burdick, M.D. and Strieter, R.M. ( 2007) Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 282: 22910-22920.
73. Horan, G.S., Wood, S., Ona, V., Li, D.J., Lukashev, M.E., Weinreb, P.H. et al. (2008) Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 177: 56-65.
74. Howell, D.C., Goldsack, N.R., Marshall, R.P., McAnulty, R.J., Starke, R., Purdy, G. et al. (2001) Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor MRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159: 1383-1395.
75. Howell, D.C., Johns, R.H., Lasky, J.A., Shan, B., Scotton, C.J., Laurent, G.J. et al. (2005) Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 166: 1353-1365.
76. Howell, D.C., Laurent, G.J. and Chambers, R.C. ( 2002) Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem Soc Trans 30: 211-216.
77. Huang, X., Wu, J., Zhu, W., Pytela, R. and Sheppard, D. ( 1998) Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice. Am J Respir Cell Mol Biol 19: 636-642.
78. Hubbard, R., Johnston, I. and Britton, J. ( 1998) Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 113: 396-400.
79. Hubbard, R., Lewis, S., Richards, K., Johnston, I. and Britton, J. ( 1996) Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347: 284-289.
80. Humphries, J.D., Byron, A. and Humphries, M.J. ( 2006) Integrin ligands at a glance. J Cell Sci 119: 3901-3903.
81. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. ( 1998) Axin, a negative regulator of the WNT signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371-1384.
82. Imokawa, S., Sato, A., Hayakawa, H., Kotani, M., Urano, T. and Takada, A. ( 1997) Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am J Respir Crit Care Med 156: 631-636.
83. Ingram, J.L., Rice, A.B., Geisenhoffer, K., Madtes, D.K. and Bonner, J.C. ( 2004) IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-Aa and PDGF-Ralpha. FASEB J 18: 1132-1134.
84. Inoshima, I., Kuwano, K., Hamada, N., Hagimoto, N., Yoshimi, M., Maeyama, T. et al. (2004) Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 286: L1038-L1044.
85. Inoue, H. and Tanabe, T. ( 1998) Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 244: 143-148.
86. Iwano, M., Plieth, D., Danoff, T.M., Xue, C., Okada, H. and Neilson, E.G. ( 2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Investigation 110: 341-350.
87. Jain, R., Shaul, P.W., Borok, Z. and Willis, B.C. ( 2007) Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol 37: 38-47.
88. Jakubzick, C., Choi, E.S., Joshi, B.H., Keane, M.P., Kunkel, S.L., Puri, R.K. et al. (2003) Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4-and IL-13-responsive cells. J Immunol 171: 2684-2693.
89. Jenkins, R.G., Su, X., Su, G., Scotton, C.J., Camerer, E., Laurent, G.J. et al. (2006) Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116: 1606-1614.
90. Jian, H., Shen, X., Liu, I., Semenov, M., He, X. and Wang, X.F. ( 2006) SMAD3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20: 666-674.
91. Jiang, D., Liang, J., Hodge, J., Lu, B., Zhu, Z., Yu, S. et al. (2004) Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114: 291-299.
92. Jones, P.L. and Shi, Y.B. ( 2003) N-COR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr Top Microbiol Immunol 274: 237-268.
93. Karsdal, M.A., Larsen, L., Engsig, M.T., Lou, H., Ferreras, M., Lochter, A. et al. (2002) Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277: 44061-44067.
94. Katzenstein, A.L. and Myers, J.L. ( 1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157: 1301-1315.
95. Keane, M.P., Arenberg, D.A., Lynch III, J.P., Whyte, R.I., Iannettoni, M.D., Burdick, M.D. et al. (1997) The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159: 1437-1443.
96. Keane, M.P., Belperio, J.A., Arenberg, D.A., Burdick, M.D., Xu, Z.J., Xue, Y.Y. et al. (1999) IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163: 5686-5692.
97. Keane, M.P., Belperio, J.A., Burdick, M.D., Lynch, J.P., Fishbein, M.C. and Strieter, R.M. ( 2001) ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164: 2239-2242.
98. Keerthisingam, C.B., Jenkins, R.G., Harrison, N.K., Hernandez-Rodriguez, N.A., Booth, H., Laurent, G.J. et al. (2001) Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 158: 1411-1422.
99. Kelly, B.G., Lok, S.S., Hasleton, P.S., Egan, J.J. and Stewart, J.P. ( 2002) A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166: 510-513.
100. Kikuchi, A., Yamamoto, H. and Kishida, S. ( 2007) Multiplicity of the interactions of WNT proteins and their receptors. Cell Signal 19: 659-671.
101. Kim, K.K., Kugler, M.C., Wolters, P.J., Robillard, L., Galvez, M.G., Brumwell, A.N. et al. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103: 13180-13185.
102. Kim, K.K., Wei, Y., Szekeres, C., Kugler, M.C., Wolters, P.J., Hill, M.L. et al. (2009) Epithelial cell alpha3beta1 integrin links beta-catenin and SMAD signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119: 213-224.
103. Kim, M.S., Kwon, H.J., Lee, Y.M., Baek, J.H., Jang, J.E., Lee, S.W. et al. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437-443.
104. King Jr, T.E., Albera, C., Bradford, W.Z., Costabel, U., Hormel, P., Lancaster, L. et al. (2009) Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (Inspire): a multicentre, randomised, placebo-controlled trial. Lancet 374: 222-228.
105. Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, N., Hattori, K. et al. (1999) An F-box protein, Fwd1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18: 2401-2410.
106. Kohyama, T., Ertl, R.F., Valenti, V., Spurzem, J., Kawamoto, M., Nakamura, Y. et al. (2001) Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 281: L1257-L1263.
107. Kolodsick, J.E., Peters-Golden, M., Larios, J., Toews, G.B., Thannickal, V.J. and Moore, B.B. ( 2003) Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 29: 537-544.
108. Kolodsick, J.E., Toews, G.B., Jakubzick, C., Hogaboam, C., Moore, T.A., McKenzie, A. et al. (2004) Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol 172: 4068-4076.
109. Konigshoff, M., Balsara, N., Pfaff, E.M., Kramer, M., Chrobak, I., Seeger, W. et al. (2008) Functional WNT signaling is increased in idiopathic pulmonary fibrosis. PLoS One 3: e2142.
110. Konigshoff, M. and Eickelberg, O. (2010) WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 42: 21-31.
111. Konigshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O.V., Jahn, A. et al. (2009) WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119: 772-787.
112. Kotani, I., Sato, A., Hayakawa, H., Urano, T., Takada, Y. and Takada, A. ( 1995) Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 77: 493-504.
113. Kotsianidis, I., Nakou, E., Bouchliou, I., Tzouvelekis, A., Spanoudakis, E., Steiropoulos, P. et al. (2009) Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 1121-1130.
114. Kubo, H., Nakayama, K., Yanai, M., Suzuki, T., Yamaya, M., Watanabe, M. et al. (2005) Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128: 1475-1482.
115. Lawson, W.E., Grant, S.W., Ambrosini, V., Womble, K.E., Dawson, E.P., Lane, K.B. et al. (2004) Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 59: 977-980.
116. Lawson, W.E. and Loyd, J.E. ( 2006) The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proc Am Thorac Soc 3: 345-349.
117. Leask, A. and Abraham, D.J. ( 2003) The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81: 355-363.
118. Lee, C.G., Homer, R.J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V. et al. (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 194: 809-821.
119. Liu, T., Lee, Y.N., Malbon, C.C. and Wang, H.Y. ( 2002) Activation of the beta-catenin/LEF-TCF pathway is obligate for formation of primitive endoderm by mouse F9 totipotent teratocarcinoma cells in response to retinoic acid. J Biol Chem 277: 30887-30891.
120. Ma, L.J., Yang, H., Gaspert, A., Carlesso, G., Barty, M.M., Davidson, J.M. et al. (2003) Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) Mice. Am J Pathol 163: 1261-1273.
121. Magro, C.M., Allen, J., Pope-Harman, A., Waldman, W.J., Moh, P., Rothrauff, S. et al. (2003) The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol 119: 556-567.
122. Malizia, A.P., Lacey, N., Walls, D., Egan, J.J. and Doran, P.P. (2009) CUX1/WNT signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells. Exp Cell Res 315: 1819-1831.
123. Manicone, A.M., Huizar, I. and McGuire, J.K. ( 2009) Matrilysin (matrix metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(e)beta(7)-integrin). Am J Pathol 175: 2319-2331.
124. Margadant, C. and Sonnenberg, A. (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11: 97-105.
125. Marmorstein, R. and Berger, S.L. ( 2001) Structure and function of bromodomains in chromatin-regulating complexes. Gene 272: 1-9.
126. Martinet, Y., Rom, W.N., Grotendorst, G.R., Martin, G.R. and Crystal, R.G. ( 1987) Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 317: 202-209.
127. Martinez-Pomares, L., Reid, D.M., Brown, G.D., Taylor, P.R., Stillion, R.J., Linehan, S.A. et al. (2003) Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies. J Leukoc Biol 73: 604-613.
128. Mercer, P.F., Johns, R.H., Scotton, C.J., Krupiczojc, M.A., Konigshoff, M., Howell, D.C. et al. (2009) Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med 179: 414-425.
129. Moeller, A., Gilpin, S.E., Ask, K., Cox, G., Cook, D., Gauldie, J. et al. (2009) Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 588-594.
130. Moore, B.B., Paine III, R., Christensen, P.J., Moore, T.A., Sitterding, S., Ngan, R. et al. (2001) Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167: 4368-4377.
131. Moore, B.B., Peters-Golden, M., Christensen, P.J., Lama, V., Kuziel, W.A., Paine III, R. et al. (2003) Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and Mediated by PGE2. Am J Physiol Lung Cell Mol Physiol 284: L342-L349.
132. Morrisey, E.E. ( 2003) WNT signaling and pulmonary fibrosis. Am J Pathol 162: 1393-1397.
133. Moustakas, A. and Heldin, C.H. ( 2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
134. Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J. et al. (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
135. Mushiroda, T., Wattanapokayakit, S., Takahashi, A., Nukiwa, T., Kudoh, S., Ogura, T. et al. (2008) A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 45: 654-656.
136. Nakagome, K., Dohi, M., Okunishi, K., Tanaka, R., Miyazaki, J. and Yamamoto, K. ( 2006) In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. Thorax 61: 886-894.
137. Narayanan, A.S., Whithey, J., Souza, A. and Raghu, G. ( 1992) Effect of gamma-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts. Chest 101: 1326-1331.
138. Nie, M., Pang, L., Inoue, H. and Knox, A.J. ( 2003) Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone H4 acetylation. Mol Cell Biol 23: 9233-9244.
139. Nogee, L.M., Dunbar III, A.E., Wert, S.E., Askin, F., Hamvas, A. and Whitsett, J.A. ( 2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344: 573-579.
140. Nusse, R. ( 2005) WNT signaling in disease and in development. Cell Res 15: 28-32.
141. Obayashi, Y., Yamadori, I., Fujita, J., Yoshinouchi, T., Ueda, N. and Takahara, J. ( 1997) The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112: 1338-1343.
142. Okada, T., Sugie, I. and Aisaka, K. ( 1993) Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. Lymphokine Cytokine Res 12: 87-91.
143. Parambil, J.G., Myers, J.L. and Ryu, J.H. ( 2005) Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 128: 3310-3315.
144. Peao, M.N., Aguas, A.P., De Sa, C.M. and Grande, N.R. ( 1994) Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 238: 57-67.
145. Piguet, P.F., Rosen, H., Vesin, C. and Grau, G.E. ( 1993) Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis 147: 435-441.
146. Pozharskaya, V., Torres-Gonzalez, E., Rojas, M., Gal, A., Amin, M., Dollard, S. et al. (2009) Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS One 4: e7559.
147. Puthawala, K., Hadjiangelis, N., Jacoby, S.C., Bayongan, E., Zhao, Z., Yang, Z. et al. (2008) Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 177: 82-90.
148. Raghu, G., Freudenberger, T.D., Yang, S., Curtis, J.R., Spada, C., Hayes, J. et al. (2006b) High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27: 136-142.
149. Raghu, G., Weycker, D., Edelsberg, J., Bradford, W.Z. and Oster, G. ( 2006a) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174: 810-816.
150. Renzoni, E.A., Walsh, D.A., Salmon, M., Wells, A.U., Sestini, P., Nicholson, A.G. et al. (2003) Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167: 438-443.
151. Rudd, R.M., Haslam, P.L. and Turner-Warwick, M. ( 1981) Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 124: 1-8.
152. Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A. et al. (2004) SMAD3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 164: 651-663.
153. Sánchez-Elsner, T., Botella, L.M., Velasco, B., Corbí, A., Attisano, L. and Bernabéu, C. ( 2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276: 38527-35.
154. Schlessinger, A., Matsson, P., Shima, J.E., Pieper, U., Yee, S.W., Kelly, L. et al. (2010) Comparison of human solute carriers. Protein Sci 19: 412-428.
155. Schmidt, M., Sun, G., Stacey, M.A., Mori, L. and Mattoli, S. ( 2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171: 380-389.
156. Schoenherr, C.J. and Anderson, D.J. ( 1995) Silencing is golden: negative regulation in the control of neuronal gene transcription. Curr Opin Neurobiol 5: 566-571.
157. Schrier, D.J., Phan, S.H. and McGarry, B.M. ( 1983) The effects of the nude (NU/NU) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis 127: 614-617.
158. Scotton, C.J. and Chambers, R.C. ( 2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321.
159. Scotton, C.J., Krupiczojc, M.A., Konigshoff, M., Mercer, P.F., Lee, Y.C., Kaminski, N. et al. (2009) Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest 119: 2550-2563.
160. Selman, M., Pardo, A., Barrera, L., Estrada, A., Watson, S.R., Wilson, K. et al. (2006) Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 173: 188-198.
161. Selman, M., Pardo, A. and Kaminski, N. ( 2008) Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 5: e62.
162. Sempowski, G.D., Beckmann, M.P., Derdak, S. and Phipps, R.P. ( 1994) Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152: 3606-3614.
163. Sime, P.J., Xing, Z., Graham, F.L., Csaky, K.G. and Gauldie, J. ( 1997) Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776.
164. Simler, N.R., Brenchley, P.E., Horrocks, A.W., Greaves, S.M., Hasleton, P.S. and Egan, J.J. ( 2004) Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 59: 581-585.
165. Sisson, T.H., Hanson, K.E., Subbotina, N., Patwardhan, A., Hattori, N. and Simon, R.H. ( 2002) Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 283: L1023-L1032.
166. Sisson, T.H., Mendez, M., Choi, K., Subbotina, N., Courey, A., Cunningham, A. et al. (2010) Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 181: 254-263.
167. Southcott, A.M., Jones, K.P., Li, D., Majumdar, S., Cambrey, A.D., Pantelidis, P. et al. (1995) Interleukin-8-differential expression in lone fibrosing alveolitis and systemic-sclerosis. Am J Respir Crit Care Med 151: 1604-1612.
168. Sterner, D.E. and Berger, S.L. ( 2000) Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459.
169. Stewart, J.P., Egan, J.J., Ross, A.J., Kelly, B.G., Lok, S.S., Hasleton, P.S. et al. (1999) The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 159: 1336-1341.
170. Strieter, R.M. and Keane, M.P. ( 2004) Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J Clin Invest 114: 165-168.
171. Strieter, R.M. and Mehrad, B. (2009) New mechanisms of pulmonary fibrosis. Chest 136: 1364-1370.
172. Subbaramaiah, K., Lin, D.T., Hart, J.C. and Dannenberg, A.J. ( 2001) Peroxisome proliferatoractivated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. evidence for involvement of activator protein-1 and CREBbinding protein/P300. J Biol Chem 276: 12440-12448.
173. Tager, A.M., Kradin, R.L., Lacamera, P., Bercury, S.D., Campanella, G.S., Leary, C.P. et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31: 395-404.
174. Tager, A.M., Lacamera, P., Shea, B.S., Campanella, G.S., Selman, M., Zhao, Z. et al. (2008) The lysophosphatidic acid receptor lpa1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14: 45-54.
175. Taipale, J., Koli, K. and Keski-Oja, J. ( 1992) Release of transforming growth factor-beta 1 from the peri-cellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 267: 25378-25384.
176. Tanjore, H., Xu, X.C., Polosukhin, V.V., Degryse, A.L., Li, B., Han, W. et al. (2009) Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 180: 657-665.
177. Taooka, Y., Maeda, A., Hiyama, K., Ishioka, S. and Yamakido, M. ( 1997) Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 156: 260-265.
178. Taskar, V.S. and Coultas, D.B. ( 2006) Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 3: 293-298.
179. Tatler, A.L., Porte, J., Knox, A., Jenkins, G. and Pang, L. ( 2008) Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis. Biochem Biophys Res Commun 370: 239-242.
180. Thiery, J.P. and Sleeman, J.P. ( 2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
181. Thomas, A.Q., Lane, K., Phillips III, J., Prince, M., Markin, C., Speer, M. et al. (2002) Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165: 1322-1328.
182. Thrall, R.S., McCormick, J.R., Jack, R.M., McReynolds, R.A. and Ward, P.A. ( 1979) Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 95: 117-130.
183. Thrall, R.S., Phan, S.H., McCormick, J.R. and Ward, P.A. ( 1981) The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathol 105: 76-81.
184. Tiitto, L., Bloigu, R., Heiskanen, U., Paakko, P., Kinnula, V.L. and Kaarteenaho-Wiik, R. ( 2006) Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. Thorax 61: 1091-1095.
185. Tong, X., Yin, L. and Giardina, C. ( 2004) Butyrate suppresses COX-2 activation in colon cancer cells through HDAC inhibition. Biochem Biophys Res Commun 317: 463-471.
186. Tredano, M., Griese, M., Brasch, F., Schumacher, S., De Blic, J., Marque, S. et al. (2004) Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A 126A: 18-26.
187. Tsakiri, K.D., Cronkhite, J.T., Kuan, P.J., Xing, C., Raghu, G., Weissler, J.C. et al. (2007) Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 104: 7552-7557.
188. Turner-Warwick, M. ( 1963) Systemic arterial patterns in the lung and clubbing of the fingers. Thorax 18: 238-250.
189. Urnov, F.D. and Wolffe, A.P. ( 2001) Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 20: 2991-3006.
190. Vancheri, C., Failla, M., Crimi, N. and Raghu, G. (2010) Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 35: 496-504.
191. Vermeulen, M., Carrozza, M.J., Lasonder, E., Workman, J.L., Logie, C. and Stunnenberg, H.G. ( 2004) In vitro targeting reveals intrinsic histone tail specificity of the SIN3/histone deacetylase and N-COR/SMRT corepressor complexes. Mol Cell Biol 24: 2364-2372.
192. Vuga, L.J., Ben-Yehudah, A., Kovkarova-Naumovski, E., Oriss, T., Gibson, K.F., Feghali-Bostwick, C. et al. (2009) WNT5a is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583-589.
193. Waisberg, D.R., Barbas-Filho, J.V., Parra, E.R., Fernezlian, S., De Carvalho, C.R., Kairalla, R.A. et al. (2010) Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/ idiopathic pulmonary fibrosis. Hum Pathol 41: 385-391.
194. Wallace, W.A., Ramage, E.A., Lamb, D. and Howie, S.E. ( 1995) A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 101: 436-441.
195. Wang, A., Yokosaki, Y., Ferrando, R., Balmes, J. and Sheppard, D. ( 1996) Differential Regulation of airway epithelial integrins by growth factors. Am J Respir Cell Mol Biol 15: 664-672.
196. Wang, Q., Wang, Y., Hyde, D.M., Gotwals, P.J., Koteliansky, V.E., Ryan, S.T. et al. (1999) Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 54: 805-812.
197. Watters, L.C., Schwarz, M.I., Cherniack, R.M., Waldron, J.A., Dunn, T.L., Stanford, R.E. et al. (1987) Idiopathic pulmonary fibrosis. pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 135: 696-704.
198. Whitsett, J.A. and Weaver, T.E. ( 2002) Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347: 2141-2148.
199. Willis, B.C., Liebler, J.M., Luby-Phelps, K., Nicholson, A.G., Crandall, E.D., Du Bois, R.M. et al. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166: 1321-1332.
200. Wilson, M.S., Madala, S.K., Ramalingam, T.R., Gochuico, B.R., Rosas, I.O., Cheever, A.W. et al. (2010) Bleomycin and IL-1{beta}-mediated pulmonary fibrosis is IL-17a dependent. J Exp Med 207: 535-552.
201. Wilson, M.S. and Wynn, T.A. (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121.
202. Wipff, P.J., Rifkin, D.B., Meister, J.J. and Hinz, B. ( 2007) Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179: 1311-1323.
203. Wynn, T.A. ( 2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
204. Xie, W., Fletcher, B.S., Andersen, R.D. and Herschman, H.R. ( 1994) V-SRC induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol 14: 6531-6539.
205. Xu, M.Y., Porte, J., Knox, A.J., Weinreb, P.H., Maher, T.M., Violette, S.M. et al. (2009) Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(Q). Am J Pathol 174: 1264-1279.
206. Yang, I.V., Burch, L.H., Steele, M.P., Savov, J.D., Hollingsworth, J.W., McElvania-Tekippe, E. et al. (2007) Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 175: 45-54.
207. Yao, H.W., Xie, Q.M., Chen, J.Q., Deng, Y.M. and Tang, H.F. ( 2004) TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci 76: 29-37.
208. Yasui, H., Gabazza, E.C., Tamaki, S., Kobayashi, T., Hataji, O., Yuda, H. et al. (2001) Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 163: 1660-1668.
209. Yoon, H.-G., Choi, Y., Cole, P.A. and Wong, J. ( 2005) Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol Cell Biol 25: 324-335.
210. You, A., Tong, J.K., Grozinger, C.M. and Schreiber, S.L. ( 2001) CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc Natl Acad Sci U S A 98: 1454-1458.
211. Yu, H., Konigshoff, M., Jayachandran, A., Handley, D., Seeger, W., Kaminski, N. et al. (2008) Transgelin is a direct target of TGF-beta/SMAD3-dependent epithelial cell migration in lung fibrosis. FASEB J 22: 1778-1789.
212. Yu, Q. and Stamenkovic, I. ( 2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
213. Zeisberg, M., Yang, C., Martino, M., Duncan, M.B., Rieder, F., Tanjore, H. et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347.
214. e Zhao, J., Shi, W., Wang, Y.L., Chen, H., Bringas Jr, P., Datto, M.B. (2002) SMAD3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 282: L585-L593.
215. Zhu, Z., Homer, R.J., Wang, Z., Chen, Q., Geba, G.P., Wang, J. et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788.
216. Ziegenhagen, M.W., Schrum, S., Zissel, G., Zipfel, P.F., Schlaak, M. and Muller-Quernheim, J. ( 1998) Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 46: 223-231.